CSIMarket
 


Atara Biotherapeutics Inc   (ATRA)
Other Ticker:  
 

Cumulative Atara Biotherapeutics Inc 's Leverage Ratio for Trailing Twelve Months Period

ATRA's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

ATRA Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth - -97.11 % -71.04 % -54.71 % -39.67 %
Y / Y Total Liabilities Growth 32.24 % 33.78 % 37.09 % 32.5 % 29.63 %
Leverage Ratio for Trailing Twelve Months Period 6.51 2.35 1.33 0.98 0.76
Total Ranking # # # # #
Seq. Equity Growth - -88.53 % -48.7 % -32.32 % -27.33 %
Seq. Total Liabilities Growth 0.27 % 0.79 % -5.07 % 37.85 % 1.43 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis In the III. Quarter company had stockholder deficit.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry Atara Biotherapeutics Inc achieved the lowest Leverage Ratio for Trailing Twelve Months Period. While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are ATRA's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0 0 0
 




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Biotechnology & Pharmaceuticals Industry Leverage Ratio for Trailing Twelve Months Period
Enzon Pharmaceuticals inc   15.53 
Amgen Inc   12.76 
Ladrx Corporation  10.23 
Halozyme Therapeutics Inc   9.79 
Inhibrx Inc   7.00 
Cidara Therapeutics Inc   6.77 
Coeptis Therapeutics Holdings Inc   6.16 
Aceragen Inc   5.28 
Cyclo Therapeutics Inc   5.00 
Protalix Biotherapeutics inc   3.92 
Atara Biotherapeutics Inc   3.36 
Precision Biosciences Inc  3.12 
Armata Pharmaceuticals Inc   3.02 
Acorda Therapeutics Inc   2.92 
Prime Medicine Inc   2.85 
Alector Inc   2.64 
Windtree Therapeutics Inc  2.46 
Applied Genetic Technologies Corporation  2.25 
Adaptimmune Therapeutics Plc  2.17 
Old Ayala Inc   1.93 
Biocardia Inc  1.92 
Valneva Se  1.83 
Zura Bio Limited  1.80 
Rubius Therapeutics Inc   1.68 
Evaxion Biotech A  1.65 
Eiger Biopharmaceuticals Inc   1.65 
Champions Oncology Inc   1.63 
Gilead Sciences Inc   1.63 
Meiragtx Holdings Plc  1.63 
Pluri Inc   1.56 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com